The authors of three studies in this issue used qualitative methods to analyze patients ' stories: about being a first-time service user, about learning to become adherent to antipsychotics, and about internalized stigma. In the first study, Helen Lester, M.B.B.Ch., M.D., and fellow researchers in the United Kingdom interviewed young people at two points after enrollment in early intervention services for first-episode psychosis, which in that country are designed to continue for the first three years of illness. Patients placed a high value on the support they received from their families and key workers; however, about a third felt that three years of sustained engagement was too intensive. Many spoke of the emergence of a new self-identity, often associated with a sense of loss of the person they were before becoming ill (page 882). The second study elicited narratives about illness and medication use from patients with schizophrenia who had been in treatment for up to 34 years. Constantin Tranulis, M.D., and colleagues asked patients to focus on key turning points in the process of becoming adherent to antipsychotics. Patients' stories revealed a complex picture of medication use and refusal, in which ongoing adherence was the result of a long and painful fight with a debilitating disorder (page 888). Finally, Derrick A. Kranke, Ph.D., M.A., and colleagues interviewed a sample of adolescents who took psychiatric medications. The authors' goal was to construct a model of self-stigma among young people. The youths' narratives included three primary “plot components”: stereotype, differentiate, and protect. Being labeled “crazy” and “psycho,” feeling different from their peers, and protecting their self-image and reputation by hiding details that linked them to a mental illness were aspects of most interviewees' stories. Important differences between this model and models of self-stigma among adults are discussed (page 893).